Evaluation of Pupil Dilation Speed With the MAP Dispenser
Status:
Completed
Trial end date:
2021-06-03
Target enrollment:
Participant gender:
Summary
After screening, eligible subjects will be scheduled for 2 treatment visits where either 1
mist or 2 mists of the study drug will be administered to both eyes according to a
pre-specified randomization plan. Safety evaluations and efficacy measurements will be
performed at specified time intervals thereafter.
Pupil dilation for each treatment will be compared at each time interval.